Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP.
Marinella VeltroniFrancesco PegoraroBarbara ScappiniFrancesca BrugnoloElisa AllegroStefano ErminiAnnalisa TondoIlaria FotziFranco BambiClaudio FavrePublished in: Annals of hematology (2021)